Pathfinder Cell Therapy, Inc. (PFND)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 29, 2025
0.00%
Market Cap 667.00
Revenue (ttm) n/a
Net Income (ttm) -1.08M
Shares Out 667.16M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 47,605
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0000
Beta -33.02
RSI 38.69
Earnings Date n/a

About Pathfinder Cell Therapy

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol PFND
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.